PHP urges Assura to back its bid over KKR and Stonepeak offer

Primary Health Properties (PHP) is urging Assura to reconsider its support for the £1.7 billion takeover offer from KKR and Stonepeak, arguing that Assura's assessment of PHP's bid as posing "material risks and downsides" is inaccurate. PHP contends that upcoming UK spending plans will benefit both firms, which invest in healthcare properties leased to entities like the National Health Service.

Analysis

A competitive bidding situation has emerged for healthcare real estate investor Assura (LON:AGR), with Primary Health Properties (LON:PHP) urging Assura to favor its bid over a recommended takeover offer from U.S. private equity firms KKR (NYSE:KKR) and Stonepeak. The KKR/Stonepeak cash bid, supported by Assura's board, values Assura shares at 52.1 pence each, totaling nearly £1.7 billion. Assura's board has expressed concerns that PHP’s offer carries "material risks and downsides" for its shareholders, a view PHP contests. PHP highlights that forthcoming UK government spending plans in healthcare are expected to benefit both firms, given their focus on properties leased to entities like Britain’s National Health Service. The overall sentiment surrounding this M&A activity is mixed with an uncertain tone, reflecting the contested nature of the proposals. An external AI-driven stock analysis mentioned in the article suggests Assura (AGRP) may not be significantly undervalued, potentially adding context to the attractiveness of the current cash offer from KKR and Stonepeak.

Key Decisions for Investors

• Assura shareholders should meticulously evaluate the terms and potential risks of PHP's bid against the certainty of the 52.1 pence per share cash offer from KKR and Stonepeak, especially considering their board's current recommendation.
• Investors should consider the external assessment suggesting Assura may not be deeply undervalued, which could make the KKR/Stonepeak cash offer appear more compelling.
• Monitor the situation closely for any revised offers from PHP, further detailed justifications from Assura's board, or changes in the competitive landscape before making definitive investment decisions.
• The positive outlook for UK healthcare spending may support the underlying asset class for both PHP and Assura, which could be a factor for long-term investors irrespective of the immediate M&A outcome.